Trials / Conditions / Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
3 registered clinical trials studyying Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic NCT01190930 | Children's Oncology Group | Phase 3 |
| Completed | Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leu NCT00720109 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Completed | Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Tr NCT00036738 | Fred Hutchinson Cancer Center | Phase 2 |